Clinical trials
Pediatrics clinical trials
Below are recruiting pediatrics clinical trials, each written for real people, not researchers. We’re tracking 1,376 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07255144Recruiting
Ultrafast ultrasound imaging for children's heart conditions
This study tests a new, faster ultrasound technique to see heart structure and blood flow in children with or without congenital heart disease (CHD). It aims to improve imaging without risk, using a short scan during a regular check-up.
Pessac, FranceAges Any age - NCT07256210RecruitingPhase 2
Donor NK cells to prevent leukemia return after stem cell transplant
This trial tests whether giving donor natural killer (NK) cells after a stem cell transplant can help prevent leukemia from coming back. It is for people aged 14-25 with certain hard-to-treat leukemias who are already getting a stem cell transplant from a related donor.
MoscowAges 1 month–25 years - NCT07259343Recruiting
Cream with milk peptide for children's mild eczema
This trial tests if a special cream made with a milk protein peptide can improve mild eczema symptoms like itching and reduce bacteria on the skin in children aged 2 to 12.
Aguascalientes, AguascalientesAges 2–12 - NCT07274527Recruiting
Amnioinfusion for babies exposed to thick meconium during labor
This trial tests whether adding fluid into the womb (amnioinfusion) during labor can protect a baby's lungs and health after being exposed to thick meconium (baby's first poop). It may help reduce breathing problems and improve long-term outcomes.
Milwaukee, WisconsinAges 18 years+ - NCT07278778Recruiting
Cancer Care Companion for parents of children with cancer
This study tests a digital tool called Cancer Care Companion to help parents of children newly diagnosed with cancer. It aims to provide support and resources during your child's treatment journey.
St Louis, MissouriAges 18 years+ - NCT07287189RecruitingPhase 2
SAT-3247 for boys with Duchenne muscular dystrophy
This trial tests a new daily pill called SAT-3247 for boys with Duchenne muscular dystrophy (DMD) who are still able to walk. The goal is to see if it can help slow muscle decline.
Los Angeles, CaliforniaAges 7–9 - NCT07290556Recruiting
New standing wheelchair for kids and teens
This study tests a new kind of manual wheelchair for kids and teens that lets you stand up while moving around. It’s for people who already use a manual wheelchair and are part of a standing program.
Saint Paul, MinnesotaAges 8–17 - NCT07303140Recruiting
Liver stiffness in young people with glycogen storage disease type III
This study looks at liver stiffness (a sign of scarring, called fibrosis) in children and young adults with type III glycogen storage disease. Researchers want to see how common liver fibrosis is in this group and how it changes over time, using a non-invasive ultrasound-like test called elastography.
StrasbourgAges 1 month–21 years - NCT07304947Recruiting
Guiding blood flow during Moyamoya surgery in children
This study tests if careful monitoring and management of blood flow during surgery can help children with Moyamoya disease recover better after EDAS. It aims to improve safety and outcomes by adjusting treatment based on real-time heart function.
SeoulAges 1 month–18 years - NCT07305090Recruiting
Gut GVHD biomarker study for transplant patients
This trial aims to develop a test using multiple biomarkers to predict how well patients will respond to treatment for acute graft-versus-host disease (GVHD) affecting the gut. It focuses on patients who are receiving an allogeneic stem cell transplant.
Bologna, BolognaAges 12 years+ - NCT07305233Recruiting
A study on drug dose calculation for students
This trial tests a method to help students learn how to calculate drug doses. If you are a student with a computer or smartphone, you may be able to join.
IzmirAges Any age - NCT07314606Recruiting
Diet plus infliximab for kids with Crohn’s
This study tests if a special diet (called CDED) combined with infliximab (a biologic drug) is more effective than infliximab alone for children with newly diagnosed or relapsed moderate-to-severe Crohn’s disease. It aims to improve gut healing and reduce inflammation.
Vancouver, British ColumbiaAges 9–17 - NCT07316816Recruiting
Weight loss study for teens with severe obesity
This study evaluates how continuous glucose monitors and other wearable devices can help teens in a bariatric program lose weight. You may join if you are in the program and ready for sleeve gastrectomy or GLP-1 medication.
Palo Alto, CaliforniaAges 10–18 - NCT07319078Recruiting
Online treatment for kids with stomach pain
This study tests an internet-based program to help children and teens with certain long-term stomach conditions, like irritable bowel syndrome (IBS) or ongoing stomach pain. It aims to see if online tools can reduce symptoms and improve daily life.
StockholmAges 8–17 - NCT07323069Recruiting
Nurse-led sleep program for children with cancer
This trial tests a special nurse-led program to help children with cancer sleep better. It includes simple steps to improve sleep and is designed for kids who are between 6 and 12 years old and currently getting cancer treatment.
Kowloon BayAges 6–12 - NCT07581457Recruiting
Tranexamic Acid to Reduce Bleeding in Scoliosis Surgery
This study tests whether a medication called tranexamic acid can safely reduce blood loss during surgery to straighten the spine in teenagers with idiopathic scoliosis (a curved spine with no known cause). The goal is to help patients need fewer blood transfusions and recover better.
PoznanAges 10–18 - NCT00870064Recruiting
Study of treating small open bone breaks in children
This study looks at how to treat certain small open fractures (where a bone has broken through the skin) in children using non-surgical realignment when possible. It may help doctors confirm the best early treatment approach for less severe injuries.
Chicago, IllinoisAges 3–14 - NCT07351227Recruiting
Comparing devices for placing a breathing tube in children
This study compares two different devices used to help place a breathing tube in children during surgery. It aims to find out which device works better for young children having planned operations.
São Paulo, São PauloAges 6 months–3 years - NCT07354126Recruiting
Flunarizine vs. propranolol for migraine in children
This trial tests two medicines—flunarizine and propranolol—to see which one works better for preventing migraines in children ages 8 to 15. If your child has frequent migraines that affect their daily life, this study may help find a treatment that works for them.
Lahore, Punjab ProvinceAges 8–15 - NCT07359911Recruiting
Exercise program for teens and young adults with sarcoma starting chemo
This study tests whether a special exercise program can help young people with sarcoma better tolerate chemotherapy. It may improve how well they respond to treatment and reduce side effects.
Miami, FloridaAges 12–39 - NCT07362238RecruitingPhase 2
Daratumumab vs Rituximab for pediatric ITP
This study compares daratumumab to rituximab for children with primary immune thrombocytopenia (ITP) that hasn't improved with steroids. The goal is to find a better treatment to raise platelet counts and reduce bleeding risk.
TianjinAges 6–18 - NCT07362654Recruiting
Gluten challenge study in kids with celiac disease
This study looks at how the immune system of children with celiac disease responds to a small amount of gluten. It may help researchers understand the disease better and find new ways to monitor it.
MálagaAges 8–14 - NCT07366086RecruitingPhase 3
Long-term safety of romosozumab for osteogenesis imperfecta in children
This study follows children who previously received romosozumab in an earlier trial to check their long-term safety. It helps understand if the treatment's benefits last safely over time.
Indianapolis, IndianaAges 5–19 - NCT07366801RecruitingPhase 2/Phase 3
Preventing graft versus host disease in children with blood cancer
This trial tests if adding special immune cells (Treg cells) to a stem cell transplant from a half-matched donor can lower the risk of graft versus host disease (a serious side effect where donor cells attack the patient's body) in children and young adults with blood cancers.
MoscowAges 1–25
Hear when a new Pediatrics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pediatrics?
- Yes. Clin2 currently lists 1,376 recruiting pediatrics studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pediatrics trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pediatrics trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.